Click or Call
Phone

Click or Call

Get in touch to learn more about medical cannabis, share your thoughts & be in-the-know for exclusive offers, products, & events.

Monday to Friday
8 AM - 7 PM EST

Saturday & Sunday
9 AM - 5 PM EST

Blended

ELARA

Perfectly balanced THC + CBD blend

Elara® is a blend of Cannabis sativa and Cannabis indica hybrid strains with an approximate 1:1 ratio of THC: CBD with only mild euphoria. Elara® harmoniously blends the top characteristics of each strain into one product. Patients can benefit tremendously from the synergistic effects of THC + CBD in treating various types of medical conditions. Elara® also contains a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of CBD+THC rich products for the treatment of all conditions approved for medical cannabis.

Read More

Cartridge 300 mg

CBD ContentApprox: 50%

THC ContentApprox: 50%

CBD to THC1:1

Dosing Units

Each vaporizer 300 mg cartridge contains 1 mg CBD/THC inhalation

Total Doses

Approx: 300 inhalations per cartridge (1ml)

$45.00

Shop Now

Key Benefits

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Cartridge 600 mg

CBD ContentApprox: 50%

THC ContentApprox: 50%

CBD to THC1:1

Dosing Units

Each vaporizer 600 mg cartridge contains 2 mg THC/CBD inhalation

Total Doses

Approx: 300 inhalations per cartridge (1ml)

$90.00

Shop Now

Key Benefits

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling.

After 5-10 minutes, patients reassess symptoms. If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Drops/Tincture

CBD ContentApprox: 50%

THC Content Approx: 50%

CBD to THC1:1

Dosing Units

600 mg in 30 mL (~10 mg CBD/mL; ~10 mg THC/mL)

Total Doses

1200 drops per bottle (~0.25 mg CBD/drop; ~0.25 mg THC/drop)

$90.00

Shop Now

Key Benefits

Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.

Instructions

Elara® oil is to be administered orally.  The starting dose is 2.5 mg/kg twice daily (5 mg/kg/day). Patients are recommended to initiate treatment on the evening of Day 1 with 2.5 mg/kg.  

After 5-7 days, the dose can be gradually increased to 5 mg/kg twice a day (10 mg/kg/day). Patients who are tolerating Elara® at 5 mg/kg twice daily and who may benefit from a dosage increase can be further titrated to a maximum recommended maintenance dosage of 10 mg/kg

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Capsules

CBD ContentApprox: 50%

THC ContentApprox: 50%

CBD to THC1:1

Dosing Units

20 mg per capsule (~10 mg CBD/capsule; ~10 mg THC/capsule)

Total Doses

1200 mg (60 capsules)

$225.00

Shop Now

Key Benefits

One the most discreet and convenient forms of consumption. The cannabinoids are processed and absorbed by the way of the liver, which means effects are more prolonged than most forms of cannabis ingestion. A diverse variety of options are available.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1-2 sessions. Each session consists of taking 1 capsule and waiting for desired effects. After 1-2 hours, patients reassess symptoms.

If symptoms have improved or subsided, no additional dosing is needed and patients take the next dose that evening/ the morning of Day 2. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Topical

CBD ContentApprox: 50%

THC Content Approx: 50%

CBD to THC1:1

Dosing Units

600 mg in 60 mL (~10 mg CBD/mL; ~10 mg THC/mL)

Total Doses

600 mg topical per 2 fl oz

$120.00

Shop Now

Key Benefits

The cannabinoids are absorbed directly into the skin for more focused therapeutic effects. Ideal for localized pain and inflammation with no psychoactive effects. Newer patients and those with a low THC tolerance can apply topicals with confidence.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1 – 3 topical applications of a small amount cream. After 45 min – 1 hour, patients reassess symptoms.

If symptoms have improved or subsided, no additional applications are needed and patients can apply topical as needed. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

Suppositories

CBD ContentApprox: 50%

THC ContentApprox: 50%

CBD to THC1:1

Dosing Units

30 mg / suppository (~15 mg CBD/suppository; ~15 mg THC/suppository)

Total Doses

30 suppositories per package

$200.00

Shop Now

Key Benefits

Ideal for localized pain, cramps and inflammation with prolonged effects. The absorption rate is very high and like other suppositories, the application puts the medication closer to internal cellular walls so essential cannabinoids enter the bloodstream much more quickly.

Instructions

Patients are recommended to initiate treatment on the evening of Day 1 with 1 application. Remove suppository from packaging and insert rectally or vaginally. After 1 – 2 hours, patients reassess symptoms.

If symptoms have improved or subsided, no additional applications are needed and patients can apply as needed. Relief for patients with chronic neuropathic pain who have not responded adequately to other pain medication.

Warnings

Elara® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;  
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.

    Find Dispensaries and PhysiciansMore locations coming soon.